Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 43,293 | 42,697 | 48,148 | 34,658 | 11,255 |
| Gross Profit | 43,293 | 42,697 | 48,148 | 34,658 | 11,255 |
| Operating Expenses | 33,655 | 24,101 | 26,138 | 23,712 | 22,424 |
| Operating Income | 9,638 | 18,596 | 22,011 | 10,946 | -11,169 |
| Other Income | 2,241 | 1,740 | 1,886 | 1,091 | 410 |
| Pre-tax Income | 11,879 | 20,336 | 23,897 | 12,037 | -10,759 |
| Net Income Continuous | 11,705 | 20,336 | 23,897 | 12,037 | -10,761 |
| Net Income | $11,705 | $20,336 | $23,897 | $12,037 | $-10,761 |
| EPS Basic Total Ops | 0.13 | 0.21 | 0.25 | 0.13 | -0.11 |
| EPS Basic Continuous Ops | 0.12 | 0.21 | 0.25 | 0.13 | -0.12 |
| EPS Diluted Total Ops | 0.11 | 0.21 | 0.24 | 0.13 | -0.11 |
| EPS Diluted Continuous Ops | 0.11 | 0.21 | 0.24 | 0.13 | -0.12 |
| EBITDA(a) | $11,107 | $19,951 | $23,674 | $11,967 | $-10,140 |